Αρχική World News Study Estimates That 22% Of Breast Cancers Are Overdiagnosed And Won’t Ever...

Study Estimates That 22% Of Breast Cancers Are Overdiagnosed And Won’t Ever Cause Harm

A study out of Australia has found that early detection of harmless cancer cells has led to significant overdiagnosis. This, in turn, has led to unnecessary surgery and risks. Breast cancer and prostate cancer were estimated to be the most overdiagnosed cancers.Not all cancer cells are created equal and can carry different risks. People can go years or even their whole lives without knowing they have a tumor growing in their body, because it’s never going to cause them harm and doesn’t cause symptoms. Overdiagnosed cancers are those not destined to cause symptoms or death.Researchers found that improved screening methods are one reason why there has been an increase in cancer diagnosis over the last 40 years or so — even as cancer deaths have either fallen or stayed the same. They determined the risk of overdiagnosing five different cancers: breast, prostate, renal, and thyroid cancers, and melanoma.Photo: Adobe Stock/Erica Smit
The study was published in the Medical Journal of Australia and led by researchers from Bond University in Queensland.Researchers took data in Australia from 1982 and compared it to data from 2012. They found that Australian patients were much more likely to be diagnosed with cancer in 2012 — even though the risk of cancer death was not the rise.That means that up to 11,000 cancers in women and 18,000 cancers in men were detected in 2012 that may not have even needed diagnosis, let alone treatment.Photo: Adobe Stock/GorodenkoffThey found that 24% of all cancer diagnoses in men (including 16% of invasive cancer diagnoses) were overdiagnosed. They estimated that 42% of prostate cancers, 42% of renal cancers, 73% of thyroid cancers, and 58% of melanomas (with invasive melanomas coming in at 22%) were overdiagnosed.
For women, they found that 18% of all cancer diagnoses (including 8% of invasive cancer diagnoses) were overdiagnosed. They also estimated that 22% of breast cancers (with invasive breast cancers coming in at 13%), 58% of renal cancers, 73% of thyroid cancers, and 54% of melanomas (with invasive melanomas coming in at 15%) were overdiagnosed.“Cancer treatments such as surgery, radiotherapy, endocrine therapy, and chemotherapy can cause physical harm, but the risks are considered acceptable if diagnosis is appropriate,” the authors said. “When someone is unnecessarily diagnosed with cancer, however, they can only be harmed by treatment, not helped.”Photo: Adobe Stock/LStockStudio
Prostate and breast cancers are the most overdiagnosed, and this makes sense, as our methods for detecting these cancers have improved in the last several decades. After mammograms began in the ’80s, there was a 50% increase in breast cancer diagnoses in the U.S. When screening for prostate cancer began a few years later, the number of diagnoses for that doubled, too.“The problem is that some screening identifies abnormal cells that look like cancer but don’t behave like cancer,” said physician Paul Glasziou from Bond University.Photo: Adobe Stock/ugreenThis research isn’t unique to Australia, either. Research in Denmark found that mammograms often detected small tumors that may not ever pose a risk, and mammograms also didn’t lower the rate of detection for late stage tumors. Research in the UK found that for every one life saved through breast cancer screening, roughly three women will be overdiagnosed with breast cancer that would never have posed a risk. A recent study in the U.S. found that rates of thyroid cancer, kidney cancer, and melanoma are climbing, while cancer deaths have stayed the same.
“Many people have assumed that additional screening is the best thing for population health, but in fact it may not be. You don’t test a population to health,” said Gilbert Welch from Brigham Women’s Hospital.There’s not clear-cut answer to this problem, and researchers agree that screening is crucial for the fight against cancer. We just need to find the sweet spot between too much and not enough cancer testing. More research is needed.Source

NEWSLETTER

Συμπληρώστε το email σας για να λαμβάνετε τις σημαντικότερες ειδήσεις από το ogkologos.com

Βρείτε μας

2,449ΥποστηρικτέςΚάντε Like
57ΑκόλουθοιΑκολουθήστε

Διαβαστε Επίσης

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ)

ΕΞΕΛΙΞΕΙΣ ΣΤΗ ΘΕΡΑΠΕΙΑ ΤΟΥ ΜΗ-ΜΙΚΡΟΚΥΤΤΑΡΙΚΟΥ ΚΑΡΚΙΝΟΥ ΤΟΥ ΠΝΕΥΜΟΝΑ (ΜΜΚΠ) Γράφει ο Δρ Παπαδούρης Σάββας, Παθόλογος-Ογκολόγος   Ο ΜΜΚΠ βρίσκεται αναλογικά στο 80% και πλέον του συνολικού...

Διατρέχουν όντως οι καρκινοπαθείς μεγαλύτερο κίνδυνο λόγω κοροναϊού;

Σε πρακτικό επίπεδο, τα δεδομένα των σχετικών μελετών υποδηλώνουν ότι η χημειοθεραπεία ή οι άλλες αντι-νεοπλασματικές θεραπείες δεν αυξάνουν σημαντικά τον κίνδυνο θνησιμότητας από...

FDA: Η ακτινοβολία των smartphones δεν προκαλεί καρκίνο

Σε μια νέα έκθεσή της, η Υπηρεσία Τροφίμων και Φαρμάκων (FDA) των ΗΠΑ αναφέρει ότι επανεξέτασε τις σχετικές επιστημονικές έρευνες που δημοσιεύθηκαν τα τελευταία...

Νέα ανακάλυψη, νέα ελπίδα για τον καρκίνο

Ένα νεοανακαλυφθέν τμήμα του ανοσοποιητικού μας συστήματος θα μπορούσε να αξιοποιηθεί για την αντιμετώπιση όλων των ειδών καρκίνου, σύμφωνα με επιστήμονες του πανεπιστημίου Cardiff...

Καρκίνος: Ευεργετική για τους καρκινοπαθείς η άσκηση

Σημαντικά ωφέλη προσφέρει η άσκηση, ακόμη και σε ασθενείς με καρκίνο. Οι περισσότεροι ασθενείς αγνοούν τα οφέλη που μπορεί να έχει γι’ αυτούς η συχνή...

Prostate Cancer

The article is provided by Scientific Communications Officer of NIPD Genetics, Ms Marina Charitou (MSc) Prostate Cancer Awareness Prostate cancer is the second most common cancer...
- Advertisment -

Ροή Ειδήσεων

FDA Approves Companion Diagnostic to Identify NTRK Fusions in Solid Tumours for Larotrectinib

On 23 October 2020, the US Food and Drug Administration (FDA) approved the next-generation sequencing (NGS)-based FoundationOne CDx test (Foundation Medicine, Inc.) as a...

An existing blood test for ovarian cancer has been re-evaluated. The results are in.

Ovarian cancer is the sixth most common cancer in women in the UK, with about 7,400 new cases every year. This number equates to...

Teacher Is Glad She Asked for More Testing After Mammogram Failed to Detect Her Breast Cancer

Martha Gray has a long history of breast cancer in her family, so she knows that she needs to take her mammograms seriously every...

How to Stay Healthy After Cancer

I try to pack helpful advice into every follow-up visit I have with patients, focusing on little tips that help foster healthy lifestyles. This...

Feasibility and Preliminary Efficacy Results of the Beat AML Study

Precision medicine in acute myeloid leukaemia (AML) is feasible in terms of providing cytogenetic and mutational data within 7 days, allowing their rapid incorporation into...

Woman Battles Breast Cancer While Pregnant, Delivers Healthy Baby Boy

When she was six months pregnant, Desiree Doughty noticed that something seemed to be wrong with her breasts. “I noticed that one of my breasts...